SLI
1.873,20
PKT
+6,14
PKT
+0,33
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
08.04.25 | Richemont Overweight | JP Morgan Chase & Co. | |
08.04.25 | ams-OSRAM Buy | Deutsche Bank AG | |
08.04.25 | Richemont Buy | Jefferies & Company Inc. | |
08.04.25 | UBS Outperform | RBC Capital Markets | |
08.04.25 | ams-OSRAM Buy | Jefferies & Company Inc. | |
07.04.25 | Roche Buy | UBS AG | |
07.04.25 | Novartis Buy | Deutsche Bank AG | |
07.04.25 | Givaudan Add | Baader Bank | |
07.04.25 | Roche Sell | Deutsche Bank AG | |
07.04.25 | UBS Overweight | JP Morgan Chase & Co. | |
07.04.25 | ams-OSRAM Buy | Jefferies & Company Inc. | |
07.04.25 | Novartis Neutral | JP Morgan Chase & Co. | |
04.04.25 | Novartis Buy | Deutsche Bank AG | |
04.04.25 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
04.04.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
04.04.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
03.04.25 | Roche Sell | Deutsche Bank AG | |
03.04.25 | Richemont Buy | UBS AG | |
03.04.25 | Novartis Buy | Deutsche Bank AG | |
03.04.25 | Novartis Outperform | Bernstein Research | |
03.04.25 | Roche Outperform | Bernstein Research | |
03.04.25 | Givaudan Buy | Goldman Sachs Group Inc. | |
03.04.25 | Roche Underweight | JP Morgan Chase & Co. | |
02.04.25 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
01.04.25 | Richemont Sector Perform | RBC Capital Markets | |
31.03.25 | Zurich Insurance Sell | UBS AG | |
31.03.25 | Swiss Re Buy | UBS AG | |
28.03.25 | ams-OSRAM Buy | Jefferies & Company Inc. | |
28.03.25 | Richemont Outperform | Bernstein Research | |
28.03.25 | Richemont Buy | UBS AG | |
28.03.25 | Richemont Sector Perform | RBC Capital Markets | |
27.03.25 | Nestlé Underperform | Jefferies & Company Inc. | |
27.03.25 | UBS Buy | Goldman Sachs Group Inc. | |
26.03.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
26.03.25 | Roche Underweight | JP Morgan Chase & Co. | |
25.03.25 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
25.03.25 | Nestlé Neutral | UBS AG | |
25.03.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
25.03.25 | UBS Overweight | JP Morgan Chase & Co. | |
24.03.25 | Richemont Outperform | Bernstein Research |